Literature DB >> 10610015

Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.

C M Weingarten1, M J Rybak, B E Jahns, J G Stevenson, W J Brown, D P Levine.   

Abstract

In 1990 there was a sudden increase in the incidence of colonization and infection due to Acinetobacter baumannii (AB) in our intensive care units (ICUs). The isolates were multiply resistant to beta-lactam and aminoglycoside antibiotics, but remained susceptible to imipenem, amikacin, and ampicillin-sulbactam. We examined the frequency of infection and colonization with AB and the effects of increased imipenem and amikacin therapy on Pseudomonas aeruginosa. We also used disease-matched controls to determine the clinical and financial impacts of treating colonization. All patients with at least one AB isolate from January-December 1992 were identified retrospectively and classified as infected or colonized based on published Centers for Disease Control criteria; the control group was selected from a computerized medical records data base matching primary diagnostic codes (102 patients both groups). The 102 patients yielded 140 isolates, 124 resistant AB and 16 sensitive AB. Thirty three patients were infected, 69 colonized. Mortality correlated with APACHE II scores. Patients acquired the organism approximately 2 weeks after admission; they had a mean ICU stay of 27.35 days, compared with 5.53 days for controls. Patients with positive AB cultures required significantly more use of ventilators than those with negative AB cultures. They also had significantly longer hospital stay, more bed transfers, greater duration and number of antibiotics, and higher hospital and pharmacy charges. Unnecessary treatment for colonization with either imipenem or amikacin resulted in a substantial decrease of P. aeruginosa susceptibility to each agent. The financial impact of treating colonization was significant and is a potential area for cost avoidance. Our results emphasize the need to extubate and move patients to non-ICU beds as soon as possible to decrease the risk of nosocomial infection. It also highlights the need to avoid treating colonization, thus avoiding unnecessary antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10610015     DOI: 10.1592/phco.19.13.1080.31597

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  9 in total

1.  Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections.

Authors:  A C Tonacio; M S Oliveira; L M S Malbouisson; A S Levin
Journal:  Infection       Date:  2013-10-30       Impact factor: 3.553

2.  Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.

Authors:  Leticia V Bentancor; Abhisek Routray; Cagla Bozkurt-Guzel; Ana Camacho-Peiro; Gerald B Pier; Tomás Maira-Litrán
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

3.  Economic value of Acinetobacter baumannii screening in the intensive care unit.

Authors:  B Y Lee; S M McGlone; Y Doi; R R Bailey; L H Harrison
Journal:  Clin Microbiol Infect       Date:  2011-04-04       Impact factor: 8.067

4.  Economic impact of Acinetobacter baumannii infection in the intensive care unit.

Authors:  Bruce Y Lee; Sarah M McGlone; Yohei Doi; Rachel R Bailey; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-10       Impact factor: 3.254

Review 5.  Economic impact of antimicrobial resistance.

Authors:  J E McGowan
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

Review 6.  Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Ilias I Siempos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.

Authors:  Jennifer Townsend; An Na Park; Rita Gander; Kathleen Orr; Doramarie Arocha; Song Zhang; David E Greenberg
Journal:  Open Forum Infect Dis       Date:  2015-03-12       Impact factor: 3.835

8.  Modeling the impact of interventions against Acinetobacter baumannii transmission in intensive care units.

Authors:  Tan N Doan; David C M Kong; Caroline Marshall; Carl M J Kirkpatrick; Emma S McBryde
Journal:  Virulence       Date:  2015-08-07       Impact factor: 5.882

9.  Clinical and Economic Evaluation of Multidrug-Resistant Acinetobacter baumannii Colonization in the Intensive Care Unit.

Authors:  Hojin Lee; Hyuck Lee
Journal:  Infect Chemother       Date:  2016-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.